Veltri J C, Rollins D E
Intermountain Regional Poison Control Center, Salt Lake City, UT 84132.
Am J Emerg Med. 1988 Mar;6(2):104-7. doi: 10.1016/0735-6757(88)90044-7.
During 1984, 62,837 cases of human exposure to analgesics were reported to the National Data Collection System of the American Association of Poison Control Centers. We undertook a comparative study of 10,134 cases of human exposure to adult formulations of aspirin, acetaminophen, and ibuprofen from which we found that human exposures to analgesics are a common problem reported to poison control centers. All three analgesics studied appear to have minimal toxicity in children who accidentally ingest the product and report the exposure to a poison control center. Most children were managed without referral to a health care facility and without specific therapeutic intervention, other than palliative measures; only a few children develop symptoms from the exposure. When symptoms developed, most were not life-threatening and the child returned to a preexposure state of health within a short time after the onset of symptoms. In adults, the analgesics appear to be relatively safe--that is, most cases had either no effect or caused only minor symptoms; less than 5% of the patients developed a major effect and less than 0.5% died as a result of their exposure. Because the majority of adults took the analgesic intentionally, the low rate of serious effect is notable. Fewer adult patients who ingested ibuprofen were hospitalized or experienced a major effect as a result of their exposure than patients ingesting aspirin or acetaminophen. No deaths were reported in the ibuprofen group.
1984年期间,62837例人体接触镇痛药的病例被报告给美国毒物控制中心协会的国家数据收集系统。我们对10134例人体接触成人用阿司匹林、对乙酰氨基酚和布洛芬制剂的病例进行了一项比较研究,从中发现人体接触镇痛药是向毒物控制中心报告的一个常见问题。所研究的这三种镇痛药似乎对意外摄入产品并向毒物控制中心报告接触情况的儿童毒性极小。大多数儿童无需转诊至医疗机构,除了采取姑息措施外也无需进行特殊治疗干预;只有少数儿童因接触而出现症状。当出现症状时,大多数症状并不危及生命,儿童在症状出现后短时间内即可恢复到接触前的健康状态。在成年人中,这些镇痛药似乎相对安全——也就是说,大多数病例要么没有影响,要么只引起轻微症状;不到5%的患者出现严重影响,因接触而死亡的患者不到0.5%。由于大多数成年人是故意服用镇痛药的,严重影响发生率较低这一点值得注意。与服用阿司匹林或对乙酰氨基酚的患者相比,服用布洛芬的成年患者因接触而住院或出现严重影响的情况较少。布洛芬组未报告死亡病例。